Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dyslipidemia

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 61 articles:
HTML format



Single Articles


    December 2020
  1. GHOSHHAJRA BB, Foldyna B, Gaudet D, Khoury E, et al
    Coronary Atheroma Regression From Infusions of Autologous Selectively Delipidated Prebeta-HDL-Enriched Plasma in Homozygous Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2020;76:3062-3064.
    PubMed    


  2. CASTANER O, Pinto X, Subirana I, Amor AJ, et al
    Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
    J Am Coll Cardiol. 2020;76:2712-2724.
    PubMed     Abstract available


  3. KRISHNASWAMI A, Beavers C, Dorsch MP, Dodson JA, et al
    Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;76:2650-2670.
    PubMed     Abstract available


    November 2020
  4. BHATT DL, Budoff MJ, Mason RP
    A Revolution in Omega-3 Fatty Acid Research.
    J Am Coll Cardiol. 2020;76:2098-2101.
    PubMed    


    October 2020
  5. MECHANICK JI, Rosenson RS, Pinney SP, Mancini DM, et al
    Coronavirus and Cardiometabolic Syndrome: JACC Focus Seminar.
    J Am Coll Cardiol. 2020;76:2024-2035.
    PubMed     Abstract available


    September 2020
  6. BOCCARA F, Rosenson RS
    Reply: Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients.
    J Am Coll Cardiol. 2020;76:1503-1504.
    PubMed    


  7. SINGH A, Mittal S, Kazimuddin M
    Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients.
    J Am Coll Cardiol. 2020;76:1503.
    PubMed    


  8. ROSENSON RS, Colantonio LD, Goonewardena SN
    Optimizing Cholesterol Management Improves the Benefits of Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2020;76:1451-1454.
    PubMed    


    July 2020
  9. THOMPSON GR
    PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia: Useful But Seldom Sufficient.
    J Am Coll Cardiol. 2020;76:143-145.
    PubMed    


  10. BLOM DJ, Harada-Shiba M, Rubba P, Gaudet D, et al
    Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia: The ODYSSEY HoFH Trial.
    J Am Coll Cardiol. 2020;76:131-142.
    PubMed     Abstract available


    June 2020
  11. TOTH PP
    Familial Hypercholesterolemia and Lipoprotein(a): Unraveling the Knot That Binds Them.
    J Am Coll Cardiol. 2020;75:2694-2697.
    PubMed    


  12. TRINDER M, DeCastro ML, Azizi H, Cermakova L, et al
    Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2020;75:2682-2693.
    PubMed     Abstract available


    May 2020
  13. KASTELEIN JJP, Reeskamp LF, Hovingh GK
    Familial Hypercholesterolemia: The Most Common Monogenic Disorder in Humans.
    J Am Coll Cardiol. 2020;75:2567-2569.
    PubMed    


  14. BEHESHTI SO, Madsen CM, Varbo A, Nordestgaard BG, et al
    Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.
    J Am Coll Cardiol. 2020;75:2553-2566.
    PubMed     Abstract available


  15. BOCCARA F, Kumar PN, Caramelli B, Calmy A, et al
    Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study.
    J Am Coll Cardiol. 2020;75:2570-2584.
    PubMed     Abstract available


  16. BHATT DL, Briggs AH, Reed SD, Annemans L, et al
    Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial.
    J Am Coll Cardiol. 2020;75:2297-2308.
    PubMed     Abstract available


  17. DURAN EK, Aday AW, Cook NR, Buring JE, et al
    Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
    J Am Coll Cardiol. 2020;75:2122-2135.
    PubMed     Abstract available


    April 2020
  18. DIENER HC, Hankey GJ
    Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar.
    J Am Coll Cardiol. 2020;75:1804-1818.
    PubMed     Abstract available


  19. LOPEZ-MELGAR B, Fernandez-Friera L, Oliva B, Garcia-Ruiz JM, et al
    Short-Term Progression of Multiterritorial Subclinical Atherosclerosis.
    J Am Coll Cardiol. 2020;75:1617-1627.
    PubMed     Abstract available


    February 2020
  20. DUELL PB, Fazio S
    Aggressive Treatment for Severe Forms of Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2020;75:575-577.
    PubMed    


  21. SANTOS RD, Stein EA, Hovingh GK, Blom DJ, et al
    Long-Term Evolocumab in Patients With Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2020;75:565-574.
    PubMed     Abstract available


    January 2020
  22. WEINGARTNER O, Sijbrands EJG, Lutjohann D
    Optimizing Clinical Cardiovascular Outcomes by a Personalized Approach to Add Ezetimibe to a Statin.
    J Am Coll Cardiol. 2020;75:128.
    PubMed    


    June 2019
  23. NTALLA I, Kanoni S, Zeng L, Giannakopoulou O, et al
    Genetic Risk Score for Coronary Disease Identifies Predispositions to Cardiovascular and Noncardiovascular Diseases.
    J Am Coll Cardiol. 2019;73:2932-2942.
    PubMed     Abstract available


  24. GRANGER CB, Nelson AJ, Pagidipati NJ
    Risk of Total Events With Icosapent Ethyl: Can We Reduce It?
    J Am Coll Cardiol. 2019;73:2803-2805.
    PubMed    


  25. BHATT DL, Steg PG, Miller M, Brinton EA, et al
    Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT.
    J Am Coll Cardiol. 2019;73:2791-2802.
    PubMed     Abstract available


    May 2019
  26. HOVINGH GK, Reeskamp LF, Ray KK
    Hypercholesterolemia Among Premature Infarcts: Time to Start the Clock of Familial Hypercholesterolemia Assessment.
    J Am Coll Cardiol. 2019;73:2451-2453.
    PubMed    


  27. SINGH A, Gupta A, Collins BL, Qamar A, et al
    Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.
    J Am Coll Cardiol. 2019;73:2439-2450.
    PubMed     Abstract available


  28. ZHENG KH, Tsimikas S, Pawade T, Kroon J, et al
    Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
    J Am Coll Cardiol. 2019;73:2150-2162.
    PubMed     Abstract available


  29. NATARAJAN P, Collier TS, Jin Z, Lyass A, et al
    Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.
    J Am Coll Cardiol. 2019;73:2135-2145.
    PubMed     Abstract available


    April 2019
  30. LARA KM, Levitan EB, Gutierrez OM, Shikany JM, et al
    Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease.
    J Am Coll Cardiol. 2019;73:2036-2045.
    PubMed     Abstract available


    March 2019
  31. TSIMIKAS S
    In Search of Patients With Elevated Lp(a): Seek and Ye Shall Find.
    J Am Coll Cardiol. 2019;73:1040-1042.
    PubMed    


  32. ELLIS KL, Perez de Isla L, Alonso R, Fuentes F, et al
    Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2019;73:1029-1039.
    PubMed     Abstract available


  33. JUKEMA JW, Szarek M, Zijlstra LE, de Silva HA, et al
    Patients with Recent Acute Coronary Syndrome and Polyvascular Disease Derive Large Absolute Benefit from Alirocumab: ODYSSEY OUTCOMES Trial.
    J Am Coll Cardiol. 2019 Mar 12. pii: S0735-1097(19)33921.
    PubMed     Abstract available


  34. ARNETT DK, Blumenthal RS, Albert MA, Michos ED, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary.
    J Am Coll Cardiol. 2019 Mar 7. pii: S0735-1097(19)33876.
    PubMed    


  35. ARNETT DK, Blumenthal RS, Albert MA, Michos ED, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.
    J Am Coll Cardiol. 2019 Mar 7. pii: S0735-1097(19)33877.
    PubMed    


    February 2019
  36. YANDRAPALLI S, Nabors C, Goyal A, Aronow WS, et al
    Modifiable Risk Factors in Young Adults With First Myocardial Infarction.
    J Am Coll Cardiol. 2019;73:573-584.
    PubMed     Abstract available


    December 2018
  37. FERENCE BA, Graham I, Tokgozoglu L, Catapano AL, et al
    Reprint of: Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series.
    J Am Coll Cardiol. 2018;72.
    PubMed     Abstract available


    September 2018
  38. SHAH NP, Cho L, Ahmed HM
    Familial Chylomicronemia Syndrome: Clinical Characteristics and Long-Term Cardiovascular Outcomes.
    J Am Coll Cardiol. 2018;72:1177-1179.
    PubMed    


    July 2018
  39. ALVI RM, Neilan AM, Tariq N, Awadalla M, et al
    Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure.
    J Am Coll Cardiol. 2018;72:518-530.
    PubMed     Abstract available


    April 2018
  40. RAZVI S, Jabbar A, Pingitore A, Danzi S, et al
    Thyroid Hormones and Cardiovascular Function and Diseases.
    J Am Coll Cardiol. 2018;71:1781-1796.
    PubMed     Abstract available


    March 2018
  41. WU CK, Juang JJ, Chiang JY, Li YH, et al
    The Taiwan Heart Registries: Its Influence on Cardiovascular Patient Care.
    J Am Coll Cardiol. 2018;71:1273-1283.
    PubMed     Abstract available


  42. SHAW LJ, Goyal A, Mehta C, Xie J, et al
    10-Year Resource Utilization and Costs for Cardiovascular Care.
    J Am Coll Cardiol. 2018;71:1078-1089.
    PubMed     Abstract available


    January 2018
  43. D'ERASMO L, Minicocci I, Nicolucci A, Pintus P, et al
    Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes.
    J Am Coll Cardiol. 2018;71:279-288.
    PubMed     Abstract available


    October 2017
  44. HONG KN, Fuster V, Rosenson RS, Rosendorff C, et al
    How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD.
    J Am Coll Cardiol. 2017;70:2171-2185.
    PubMed     Abstract available


  45. AMOR-SALAMANCA A, Castillo S, Gonzalez-Vioque E, Dominguez F, et al
    Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    J Am Coll Cardiol. 2017;70:1732-1740.
    PubMed     Abstract available


    August 2017
  46. LLOYD-JONES DM, Morris PB, Ballantyne CM, Birtcher KK, et al
    2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Tas
    J Am Coll Cardiol. 2017 Aug 30. pii: S0735-1097(17)38898.
    PubMed     Abstract available


  47. STEIN EA, Dann EJ, Wiegman A, Skovby F, et al
    Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations.
    J Am Coll Cardiol. 2017;70:1162-1170.
    PubMed     Abstract available


    July 2017
  48. LOPEZ-MELGAR B, Fernandez-Friera L, Oliva B, Garcia-Ruiz JM, et al
    Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study.
    J Am Coll Cardiol. 2017;70:301-313.
    PubMed     Abstract available


    June 2017
  49. KEARNS A, Gordon J, Burdo TH, Qin X, et al
    HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.
    J Am Coll Cardiol. 2017;69:3084-3098.
    PubMed     Abstract available


  50. HAO P, Jiang F, Cheng J, Ma L, et al
    Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms.
    J Am Coll Cardiol. 2017;69:2952-2966.
    PubMed     Abstract available


    April 2017
  51. DU X, Dong J, Ma C
    Is Atrial Fibrillation a Preventable Disease?
    J Am Coll Cardiol. 2017;69:1968-1982.
    PubMed     Abstract available


    March 2017
  52. YAN AT, Koh M, Chan KK, Guo H, et al
    Association Between Cardiovascular Risk Factors and Aortic Stenosis: The CANHEART Aortic Stenosis Study.
    J Am Coll Cardiol. 2017;69:1523-1532.
    PubMed     Abstract available


    February 2017
  53. ROBINSON JG, Rosenson RS, Farnier M, Chaudhari U, et al
    Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials.
    J Am Coll Cardiol. 2017;69:471-482.
    PubMed     Abstract available


    December 2016
  54. LEVELT E, Neubauer S
    Reply: Ectopic Fat Deposition and Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68:2595.
    PubMed    


  55. GABORIT B, Dutour A
    Ectopic Fat Deposition and Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68:2594-2595.
    PubMed    


    July 2016
  56. BESSELING J, Hovingh GK, Huijgen R, Kastelein JJ, et al
    Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.
    J Am Coll Cardiol. 2016;68:252-60.
    PubMed     Abstract available


    June 2016
  57. HSU JC, Maddox TM, Kennedy K, Katz DF, et al
    Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.
    J Am Coll Cardiol. 2016;67:2913-23.
    PubMed     Abstract available


  58. MURPHY SA, Cannon CP, Blazing MA, Giugliano RP, et al
    Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?
    J Am Coll Cardiol. 2016;67:3025-6.
    PubMed    


  59. MASCITELLI L, Goldstein MR
    Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?
    J Am Coll Cardiol. 2016;67:3025.
    PubMed    


  60. GIDDING SS
    Familial Hypercholesterolemia: Now Part of Cardiovascular Disease Genetic Epidemiology Research.
    J Am Coll Cardiol. 2016;67:2590-2.
    PubMed    


    April 2016
  61. HERTTUA K, Martikainen P, Batty GD, Kivimaki M, et al
    Poor Adherence to Statin and Antihypertensive Therapies as Risk Factors for Fatal Stroke.
    J Am Coll Cardiol. 2016;67:1507-15.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: